Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer
Buze Chen(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Xiaojuan Ding(Chongqing Medical University), Xin Qi(Suzhou University of Science and Technology), Haihong Wang(Xuzhou Medical College), Ailing Wan(Xuzhou Medical College), Xiaoman Lin(Xuzhou Medical College), Wenyu Mu(Xuzhou Medical College), Gang Wang(Jiangsu University)
Cited by 11
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
A simple electrochemical biosensor for highly sensitive and specific detection of microRNA based on mismatched catalytic hairpin assembly
|Biosensors and Bioelectronics|2015|153
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation
|Cell Death and Differentiation|2014|116